BeyondSpring Inc. (BYSI) stock
BYSINasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.56−0.02 (-3.27%)
Close on Nov 17, 2026Market cap $23.02MP/E –Yield –
BeyondSpring operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
BeyondSpring's operating income for the twelve months ending Jun 30, 2026 was -$8.35M. For fiscal 2025 it was -$8.95M. The highest annual figure on record is -$2.11M in fiscal 2014.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.95M | – |
| FY2024 | Dec 31, 2024 | -$8.75M | – |
| FY2023 | Dec 31, 2023 | -$15.08M | – |
| FY2022 | Dec 31, 2022 | -$37.24M | – |
| FY2021 | Dec 31, 2021 | -$66.24M | – |
| FY2020 | Dec 31, 2020 | -$64.21M | – |
| FY2019 | Dec 31, 2019 | -$40.31M | – |
| FY2018 | Dec 31, 2018 | -$57.55M | – |
| FY2017 | Dec 31, 2017 | -$97.98M | – |
| FY2016 | Dec 31, 2016 | -$12.37M | – |
| FY2015 | Dec 31, 2015 | -$7.48M | – |
| FY2014 | Dec 31, 2014 | -$2.11M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.73M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.23M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.60M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.79M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.95M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.61M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.70M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.36M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.64M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.06M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.49M | – |
| Q3 FY2021 | Sep 30, 2021 | -$18.35M | – |
| Q2 FY2021 | Jun 30, 2021 | -$19.98M | – |
| Q1 FY2021 | Mar 31, 2021 | -$17.42M | – |
| Q4 FY2020 | Dec 31, 2020 | -$18.62M | – |
| Q3 FY2020 | Sep 30, 2020 | -$15.35M | – |
| Q2 FY2020 | Jun 30, 2020 | -$13.62M | – |
| Q1 FY2020 | Mar 31, 2020 | -$16.63M | – |
| Q4 FY2019 | Dec 31, 2019 | -$15.29M | – |
| Q3 FY2019 | Sep 30, 2019 | -$9.70M | – |
| Q2 FY2019 | Jun 30, 2019 | -$7.35M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.97M | – |
| Q4 FY2018 | Dec 31, 2018 | -$14.71M | – |
| Q3 FY2018 | Sep 30, 2018 | -$15.65M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.38M | – |
| Q1 FY2018 | Mar 31, 2018 | -$14.80M | – |
| Q4 FY2017 | Dec 31, 2017 | -$16.54M | – |
| Q3 FY2017 | Sep 30, 2017 | -$18.62M | – |
| Q2 FY2017 | Jun 30, 2017 | -$15.03M | – |
| Q1 FY2017 | Mar 31, 2017 | -$47.79M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.48M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.28M | – |
| Q2 FY2016 | Jun 30, 2016 | -$3.69M | – |
| Q1 FY2016 | Mar 31, 2016 | -$1.92M | – |
See a number that looks wrong?